
Sign up to save your podcasts
Or


Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that identify gene variants associated with MS severity/progression, an AI program that read EEGs accurately, and butylphthalide as a promising neuroprotective agent for ischemic stroke.
By American Academy of Neurology4.7
1919 ratings
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that identify gene variants associated with MS severity/progression, an AI program that read EEGs accurately, and butylphthalide as a promising neuroprotective agent for ischemic stroke.

137 Listeners

322 Listeners

498 Listeners

296 Listeners

49 Listeners

13 Listeners

191 Listeners

93 Listeners

514 Listeners

136 Listeners

368 Listeners

190 Listeners

374 Listeners

6 Listeners

83 Listeners